Evidence map›Paper›PMID 42020702›Full record

ArticleScientific reports2026

Cytotoxicity and antibacterial BioEffects of CuO-Zn nanoparticles synthesized from Lactobacillus helveticus yogurt isolates targeting RsbA gene expression.

Mais Emad Ahmed, Waqar Adnan Hamdan Al Kubaisi, Hiba Mahdi Mahmood Alhashimi, Mohammad Y Alfaifi, Ali A Shati, Serag Eldin I Elbehairi, Mohammed Aufy, Ahmed M Hussein

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Antibiofilm potential of biogenic magnesium oxide nanoparticles against multidrug resistant gram-negative bacteria.International microbiology : the official journal of the Spanish Society for Microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mais Emad AhmedDepartment of Biology, College of Science, University of Baghdad, Baghdad, Iraq. mais.emad@sc.uobaghdad.edu.iq.ORCID http://orcid.org/0000-0003-4961-4532
Waqar Adnan Hamdan Al KubaisiDepartment of Basic Sciences, College of Dentistry, University of Kerbala, Kerbala, Iraq.
Hiba Mahdi Mahmood AlhashimiDepartment of Microbiology, College of Medicine, University of Kerbala, Kerbala, Iraq.
Mohammad Y AlfaifiCentral Labs, King Khalid University, Alqura'a, Abha, Saudi Arabia.
Ali A ShatiBiology Department, Faculty of Science, King Khalid University, Abha, 9004, Saudi Arabia.
Serag Eldin I ElbehairiBiology Department, Faculty of Science, King Khalid University, Abha, 9004, Saudi Arabia.
Mohammed AufyDepartment of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria.
Ahmed M HusseinDepartment of Pharmaceutical Sciences, Division of Pharmacology and Toxicology, University of Vienna, Vienna, Austria. ahmed.hussein@univie.ac.at.ORCID http://orcid.org/0000-0002-7315-9886

Funding

Central labs at King Khalid University (CL/CO/B/3)
6 · The paper itself

Abstract

Proteus mirabilis is an opportunistic urinary tract pathogen distinguished by its swarming motility and dimorphic behavior. This study examined the antibacterial potential of native Bulgarian dairy Lactobacillus strains against clinically significant P. mirabilis isolates. By developing and characterizing copper oxide (CuONPs) and zinc oxide (ZnONPs) nanoparticles as antimicrobial agents targeting P. mirabilis, this work contributes to addressing the global challenge of antimicrobial resistance, aligning with the United Nations Sustainable Development Goals (UNSDGs) that aim to reduce infectious disease mortality through innovative therapeutic approaches. Two multidrug-resistant P. mirabilis isolates (M1 and M2) displaying swarming motility were selected for analysis. The antimicrobial activity of Lactobacillus helveticus, a heterofermentative lactic acid bacterium commonly found in dairy products, was evaluated. This strain produces helveticin, a bacteriocin-like inhibitory substance (BLIS) with notable bactericidal activity. CuONPs and ZnONPs were biosynthesized using L. helveticus isolated from yogurt, with strain identity confirmed via 16 S rRNA gene sequencing. Nanoparticles were subsequently extracted and partially purified through 70% ammonium sulfate precipitation. Characterization revealed surface plasmon resonance peaks at 250 nm (CuONPs) and 300 nm (ZnONPs). AFM analysis indicated particle sizes ranging from 15 to 26 nm, while TEM imaging showed predominantly spherical to irregular morphologies between 9 and 20 nm. Cytotoxicity evaluation using the MTT assay demonstrated dose-dependent reductions in the viability of WRL68 human hepatic cells, with up to 60% inhibition at higher concentrations. Notably, both nanoparticle types effectively inhibited P. mirabilis swarming motility, and qPCR analysis confirmed significant downregulation of the rsbA gene, a crucial regulator of this behavior. Overall, green-synthesized CuONPs and ZnONPs derived from L. helveticus displayed potent anti-swarming and antivirulence effects against P. mirabilis. Their ability to suppress virulence-associated gene expression underscores their promise as eco-friendly antimicrobial agents for managing opportunistic pathogens and mitigating multidrug resistance.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsCopperLactobacillus helveticusMetal NanoparticlesProteus mirabilisYogurtZinc OxideHumansMicrobial Sensitivity TestsNanoparticlesAnti-Bacterial AgentsBacterial ProteinsCopperZinc OxideCopper nanoparticlesGreen synthesized nanoparticlesL. helveticusZinc oxide nanoparticles

Identifiers

PMID42020702
PMCPMC13272949

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.